Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Anti-dysimmune treatment

Engel WK, Hopkins LC, Rosenberg BJ. (1985) Fasci-culating progressive muscular atrophy (F-PMA) remarkably responsive to anti-dysimmune treatment (ADIT)-a possible clue to more ordinary ALS Neurology 35, 72. [Pg.52]

Treatment The carcinoma was excised, and radiation and chemotherapy started. (Note certain forms of anticancer chemotherapy can themselves produce a toxic neuropathyr which complicates interpretation of any worsening of the patient s neuropathy.) For the probable dysimmune component of this neuropathy, the patient was also started on TVIG 0.4g/kg/ day, on two nonconsecutive days every week. He showed some improvement, but we do not know which treatment, or treatments, should receive the credit, because some anticancer treatments are also anti-dysimmune. [Pg.69]


See other pages where Anti-dysimmune treatment is mentioned: [Pg.37]    [Pg.38]    [Pg.44]    [Pg.47]    [Pg.47]    [Pg.48]    [Pg.68]    [Pg.68]    [Pg.68]    [Pg.70]    [Pg.72]    [Pg.168]    [Pg.37]    [Pg.38]    [Pg.44]    [Pg.47]    [Pg.47]    [Pg.48]    [Pg.68]    [Pg.68]    [Pg.68]    [Pg.70]    [Pg.72]    [Pg.168]    [Pg.35]    [Pg.47]    [Pg.63]    [Pg.111]    [Pg.133]    [Pg.36]   
See also in sourсe #XX -- [ Pg.47 , Pg.48 , Pg.49 , Pg.50 ]




SEARCH



© 2024 chempedia.info